Urinary tract infection diagnostic
AssigneeMologic Limited
InventorsGita Parekh, Paul Davis, Julie Thompson, Annelyse Duvoix
Life of this patent
Estimating the term…
Loading patent…
AssigneeMologic Limited
InventorsGita Parekh, Paul Davis, Julie Thompson, Annelyse Duvoix
Estimating the term…
Method for detecting a urinary tract infection (UTI) in a subject comprising determining levels of one or more biomarkers selected from MMP8, HNE, Cystatin C, MMP9, HSA, IL-8, interleukin-6 (IL-6), interleukin-1 beta (IL-1b), fibrinogen, RBP4, active MMP9 and MMP2, NGAL, Desmosine, MPO and CRP in a urine sample obtained from the subject. The determined levels may then be compared with a threshold level, wherein increased levels of at least one of the biomarkers in the urine sample relative to the threshold level is indicative of the presence of a urinary tract infection. Methods for monitoring a UTI and monitoring treatment of a UTI are also provided as are companion systems or test kits.
A method for detecting a urinary tract infection in a subject comprising:
A method for monitoring a urinary tract infection in a subject comprising:
A method for monitoring treatment of a urinary tract infection in a subject comprising:
A method of treating a urinary tract infection comprising administering an antibiotic to the subject suffering from a urinary tract infection, wherein the subject displays, in a urine sample, an increased level of at least one biomarker selected from MMP8, HNE, Cystatin C, MMP9, HSA, IL-8, interleukin-6 (IL-6), interleukin-1 beta (IL-1b), fibrinogen, RBP4, active MMP9 and MMP2, NGAL, Desmosine, MPO and CRP.
An antibiotic for use in a method of treating a urinary tract infection wherein the subject displays, in a urine sample, an increased level of at least one biomarker selected from MMP8, HNE, Cystatin C, MMP9, HSA, IL-8, interleukin-6 (IL-6), interleukin-1 beta (IL-1b), fibrinogen, RBP4, active MMP9 and MMP2, NGAL, Desmosine, MPO and CRP.
A system or test kit for detecting a urinary tract infection in a subject, comprising:
A system or test kit for monitoring a urinary tract infection in a subject, comprising:
A testing device, testing kit or testing composition of matter comprising:
The testing device, testing kit or testing composition of matter of any one of claims 24-29 further comprising a vessel for collecting a urine sample. 31 The testing device, testing kit or testing composition of matter of any one of claims 24-30 further comprising a visual aid displaying different test line intensity patterns from which the user can interpret the observed test line results.
The testing device, testing kit or testing composition of matter of any one of claims 24-31 further comprising a reader to determine levels of the markers at the respective test lines. 33 The testing device, testing kit or testing composition of matter of claim 32 wherein the reader comprises:
Dependencies are inferred from the claim text.